Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page adds new help/navigation sections (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading, removing the prior Intervention / Treatment label and the v3.5.5 revision reference; the revision note now shows Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:30:31.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays a new revision tag (Revision: v3.5.5) replacing the previous v3.5.4. This reflects a software or template update rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-05T16:13:30.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-15T05:50:06.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor platform/release change without altering the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:23.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:09.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T08:53:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.